Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

InspireMD, Inc. announced that the FDA has granted premarket approval of the company’s CGuard Prime carotid stent system in ...

Vivasure Medical announced that it has received European CE Mark approval for an expanded indication for its fully bioresorbable, ...

Gore & Associates announced that the company’s TAG thoracic branch endoprosthesis (TBE) has received FDA approval for us ...

AngioDynamics, Inc. announced first patient enrollment in the RECOVER-AV clinical trial. The prospective, multicenter, multination ...

Endovascular Engineering, Inc. (E2) announced the completion of patient enrollment in the pivotal cohort of the ENGULF investigati ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing ...

Gore & Associates: Gore Viabahn Endoprosthesis With Heparin Bioactive Surface Nitinol/ePTFE, gold: 6–10: 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) ...